Metformin treatment inhibits motility and invasion of glioblastoma cancer cells

Glioblastoma multiforme (GBM) is one of the most common and deadliest cancers of the central nervous system (CNS). GBMs high ability to infiltrate healthy brain tissues makes it difficult to remove surgically and account for its fatal outcomes. To improve the chances of survival, it is critical to s...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Al Hassan, Marwa (author)
مؤلفون آخرون: Fakhoury, Isabelle (author), El Masri, Zeinab (author), Ghazale, Noura (author), Dennaoui, Rayane (author), El Atat, Oula (author), Kanaan, Amjad (author), El-Sibai, Mirvat (author)
التنسيق: article
منشور في: 2018
الوصول للمادة أونلاين:http://hdl.handle.net/10725/11397
https://doi.org/10.1155/2018/5917470
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.hindawi.com/journals/acp/2018/5917470/abs/
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513488715513856
author Al Hassan, Marwa
author2 Fakhoury, Isabelle
El Masri, Zeinab
Ghazale, Noura
Dennaoui, Rayane
El Atat, Oula
Kanaan, Amjad
El-Sibai, Mirvat
author2_role author
author
author
author
author
author
author
author_facet Al Hassan, Marwa
Fakhoury, Isabelle
El Masri, Zeinab
Ghazale, Noura
Dennaoui, Rayane
El Atat, Oula
Kanaan, Amjad
El-Sibai, Mirvat
author_role author
dc.creator.none.fl_str_mv Al Hassan, Marwa
Fakhoury, Isabelle
El Masri, Zeinab
Ghazale, Noura
Dennaoui, Rayane
El Atat, Oula
Kanaan, Amjad
El-Sibai, Mirvat
dc.date.none.fl_str_mv 2018
2019-10-08T12:44:05Z
2019-10-08T12:44:05Z
2019-10-08
dc.identifier.none.fl_str_mv 2210-7185
http://hdl.handle.net/10725/11397
https://doi.org/10.1155/2018/5917470
Al Hassan, M., Fakhoury, I., El Masri, Z., Ghazale, N., Dennaoui, R., El Atat, O., ... & El-Sibai, M. (2018). Metformin treatment inhibits motility and invasion of glioblastoma cancer cells. Analytical Cellular Pathology, 2018.
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.hindawi.com/journals/acp/2018/5917470/abs/
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Analytical Cellular Pathology
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv Metformin treatment inhibits motility and invasion of glioblastoma cancer cells
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Glioblastoma multiforme (GBM) is one of the most common and deadliest cancers of the central nervous system (CNS). GBMs high ability to infiltrate healthy brain tissues makes it difficult to remove surgically and account for its fatal outcomes. To improve the chances of survival, it is critical to screen for GBM-targeted anticancer agents with anti-invasive and antimigratory potential. Metformin, a commonly used drug for the treatment of diabetes, has recently emerged as a promising anticancer molecule. This prompted us, to investigate the anticancer potential of metformin against GBMs, specifically its effects on cell motility and invasion. The results show a significant decrease in the survival of SF268 cancer cells in response to treatment with metformin. Furthermore, metformin’s efficiency in inhibiting 2D cell motility and cell invasion in addition to increasing cellular adhesion was also demonstrated in SF268 and U87 cells. Finally, AKT inactivation by downregulation of the phosphorylation level upon metformin treatment was also evidenced. In conclusion, this study provides insights into the anti-invasive antimetastatic potential of metformin as well as its underlying mechanism of action.
eu_rights_str_mv openAccess
format article
id LAURepo_3fcaff5c7a3d8144f714a08aa1b280b7
identifier_str_mv 2210-7185
Al Hassan, M., Fakhoury, I., El Masri, Z., Ghazale, N., Dennaoui, R., El Atat, O., ... & El-Sibai, M. (2018). Metformin treatment inhibits motility and invasion of glioblastoma cancer cells. Analytical Cellular Pathology, 2018.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/11397
publishDate 2018
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Metformin treatment inhibits motility and invasion of glioblastoma cancer cellsAl Hassan, MarwaFakhoury, IsabelleEl Masri, ZeinabGhazale, NouraDennaoui, RayaneEl Atat, OulaKanaan, AmjadEl-Sibai, MirvatGlioblastoma multiforme (GBM) is one of the most common and deadliest cancers of the central nervous system (CNS). GBMs high ability to infiltrate healthy brain tissues makes it difficult to remove surgically and account for its fatal outcomes. To improve the chances of survival, it is critical to screen for GBM-targeted anticancer agents with anti-invasive and antimigratory potential. Metformin, a commonly used drug for the treatment of diabetes, has recently emerged as a promising anticancer molecule. This prompted us, to investigate the anticancer potential of metformin against GBMs, specifically its effects on cell motility and invasion. The results show a significant decrease in the survival of SF268 cancer cells in response to treatment with metformin. Furthermore, metformin’s efficiency in inhibiting 2D cell motility and cell invasion in addition to increasing cellular adhesion was also demonstrated in SF268 and U87 cells. Finally, AKT inactivation by downregulation of the phosphorylation level upon metformin treatment was also evidenced. In conclusion, this study provides insights into the anti-invasive antimetastatic potential of metformin as well as its underlying mechanism of action.PublishedN/A2019-10-08T12:44:05Z2019-10-08T12:44:05Z20182019-10-08Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article2210-7185http://hdl.handle.net/10725/11397https://doi.org/10.1155/2018/5917470Al Hassan, M., Fakhoury, I., El Masri, Z., Ghazale, N., Dennaoui, R., El Atat, O., ... & El-Sibai, M. (2018). Metformin treatment inhibits motility and invasion of glioblastoma cancer cells. Analytical Cellular Pathology, 2018.http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttps://www.hindawi.com/journals/acp/2018/5917470/abs/enAnalytical Cellular Pathologyinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/113972021-03-19T10:47:37Z
spellingShingle Metformin treatment inhibits motility and invasion of glioblastoma cancer cells
Al Hassan, Marwa
status_str publishedVersion
title Metformin treatment inhibits motility and invasion of glioblastoma cancer cells
title_full Metformin treatment inhibits motility and invasion of glioblastoma cancer cells
title_fullStr Metformin treatment inhibits motility and invasion of glioblastoma cancer cells
title_full_unstemmed Metformin treatment inhibits motility and invasion of glioblastoma cancer cells
title_short Metformin treatment inhibits motility and invasion of glioblastoma cancer cells
title_sort Metformin treatment inhibits motility and invasion of glioblastoma cancer cells
url http://hdl.handle.net/10725/11397
https://doi.org/10.1155/2018/5917470
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.hindawi.com/journals/acp/2018/5917470/abs/